Sort
10,766 grants matching “checkpoint inhibitor”
Depleting S1P to reverse immune exclusion for effective cancer immunotherapy
$2,592,085Everett Stone · University Of Texas At Austin · R01 · FY2025 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,582,338Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2021 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,582,338Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2025 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,574,738Antoni Ribas · University Of California Los Angeles · P01 · FY2020 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,573,596David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2023 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,573,596Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2020 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,573,596Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,573,596Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
Targeting checkpoint inhibitors for pain control
$2,569,851Ru-Rong Ji · Duke University · RF1 · FY2023 · NS
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,564,339James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,556,789Antoni Ribas · University Of California Los Angeles · P01 · FY2022 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,556,789Antoni Ribas · University Of California Los Angeles · P01 · FY2023 · CA
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,548,990James R. Heath · Institute For Systems Biology · U54 · FY2023 · CA
Molecular Genetics of Vascular Disease
$2,548,161Elizabeth G Nabel · National Human Genome Research Institute · ZIA · FY2009 · HG
Targeted Therapies in Melanoma
$2,538,781Meenhard Herlyn · Wistar Institute · P01 · FY2019 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,690Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,688Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA
Preclinical drug development in pancreatic cancer
$2,528,211Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
LICI Microbiome and Genetics Core
$2,525,817Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,522,125Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2022 · CA
Epigenetic Therapies - New Approaches
$2,521,916Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2025 · CA
Deciphering the Achilles Heel of Cancer Immunotherapy
$2,520,000Alexandra-Chloe Villani · Massachusetts General Hospital · DP2 · FY2019 · CA
UT Southwestern Liver Cancer SPORE
$2,513,300Amit Singal · Ut Southwestern Medical Center · P50 · FY2025 · CA
Fred Hutchinson Cancer Research Center Lung SPORE
$2,509,264A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2020 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,508,454Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2021 · CA